Philippines government investigates Dengvaxia dengue vaccine

Share

The Philippines banned a government program, which involved immunizing children with Dengvaxia after releasing Sanofi's findings. The WHO Country Office said this position paper was "based on recommendations of the Strategic Group of Experts on Immunisation which met and published preliminary advice in mid-April 2016".

A statement from Sanofi said the long-term trial results highlighted "the complex nature" of dengue infection as it proposed a "label update" on the use of the vaccine.

Philippine health officials have ordered Sanofi to jerk its dengue vaccine off the market as the controversy over the health threat it poses to children continues to roil the country.

On the impact of issues surrounding the vaccine in Brazil and the Philippines, the spokesperson said, "Sanofi Pasteur has taken action to transparently share this new data with the health authorities in the countries where the vaccine is in use today or where it is now being considered for regulatory approval".

Sharad Yadav speaks after RS disqualification: My fight for democracy will continue
Yadav alongwith MP Ali Anwar were disqualified in a late night order by Rajya Sabha Chairperson M. Both of them have thus ceased to be a Member of the Rajya Sabha with immediate effect.

"In this group, all fully recovered with proper medical treatment".

To allay the fears of the public, Malacañang on Monday reminded the public to not panic over the government's dengue vaccination program, saying the Department of Justice (DOJ) will start an inquiry on the purchase of the drug.

"These included the following: first, use of the vaccine should only be considered in areas where a high proportion (preferably at least 70%) of the community had already been exposed to the virus; second, the vaccine should only be provided to people 9 years of age and above; and third, people being vaccinated should receive 3 doses", it said.

The WHO said on Monday it hoped to review safety data this month on Sanofi's dengue vaccine which the company said was approved in 19 countries and launched in 11.

IHC dismisses Nawaz Sharif's plea to club corruption references
The IHC division bench, comprising Justice Aamer Farooq and Justice Mohsin Akhtar Kayani, announced the short judgment. At the last hearing on Monday, the court approved Nawaz's exemption appearance plea.

The FDA added they are closely coordinating with DOH for any "adverse events and reactions" that may be reported by the recipients following their immunization of Dengvaxia, and vowed to immediately take appropriate measures to protect the public.

As of November 2017, about 733,713 Filipino children have been given the anti-dengue vaccine.

Dengue is a mosquito-borne tropical disease that kills about 20,000 people a year and infects hundreds of millions.

Schleckser Sells 5601 Shares of Exxon Mobil Corporation (XOM) Stock
Currently, 4.27 billion total shares are owned by the public and among those 4.23 billion shares have been available to trade. In the most updated research from a number of analysts on Wall Street, the company gets 26 Buys and 1 Sell among 34 analysts.

Share